Workflow
Evolve rodent birth control
icon
Search documents
SenesTech Announces 2025 Financial Results Driven by Strong Growth in E-Commerce
Prnewswire· 2026-03-12 20:05
Core Insights - SenesTech reported a 20% increase in revenue to $2.2 million for 2025, driven by strong growth in e-commerce channels despite a transition to direct management of Amazon sales [1][2] - The company improved its gross profit margin to 62.5% in 2025 from 54.1% in 2024, attributed to the higher margin profile of the Evolve product line and manufacturing improvements [1] - Adjusted EBITDA loss decreased to $5.3 million in 2025 from $5.8 million in 2024, reflecting revenue growth and improved gross margins [1] Financial Highlights - Cash and short-term investments reached $8.6 million at the end of 2025, providing an operating runway through approximately the second quarter of 2027 [1] - Net loss for 2025 was $6.4 million, slightly higher than the $6.2 million loss in 2024, which included one-time legal expenses of $631,000 and non-cash operating lease expenses of $135,000 [1] - E-commerce revenue surged by 88% year-over-year, with a potential growth of 130% if the transition-related revenue loss of $200,000 had been recognized [1] Operational and Strategic Highlights - The company initiated a search for a new CEO following the retirement of Joel Fruendt and appointed Dr. Jamie Bechtel as Interim Executive Chair [1] - Evolve secured regulatory approval in New Zealand and expanded its international presence in Belize [1] - Field validation studies showed a 79% reduction in rat activity at one site and over 50% at another, demonstrating the effectiveness of the Evolve product [1] E-commerce Strategy - SenesTech transitioned to directly managing Amazon sales of Evolve products, which is expected to enhance revenue and operating margins once fully integrated [1] - The transition to direct management resulted in an estimated $200,000 revenue impact in the fourth quarter, but management anticipates higher revenue and stronger margins in the future [1]
SenesTech to Report Fourth Quarter and Fiscal Year 2025 Financial Results on Thursday, March 12, 2026
Prnewswire· 2026-03-09 20:15
Core Viewpoint - SenesTech, Inc. will report its financial results for the fourth quarter and fiscal year 2025 on March 12, 2026, after market close, with a conference call scheduled for the same day at 5:00 p.m. Eastern time [1]. Financial Reporting - The financial results will cover the period ended December 31, 2025, and will be accessible via a live webcast on the company's Investor Relations website [1]. - A replay of the conference call will be available for at least 90 days following the event [1]. Company Overview - SenesTech is focused on managing rodent populations through innovative birth control solutions, aiming to create healthier environments [1]. - The company's flagship product, Evolve rodent birth control, is designed to enhance pest management programs while reducing reliance on traditional poisons [1]. - SenesTech's mission includes creating cleaner cities, more efficient businesses, and healthier communities through effective and sustainable products [1].
SenesTech to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
Prnewswire· 2025-09-17 20:15
Core Points - SenesTech, Inc. will participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025, with a webcast presentation and one-on-one meetings with investors [1][3] - The webcast presentation is scheduled for 2:45 p.m. ET and will be accessible online, with a replay available after the event [2] - SenesTech focuses on humane management of animal pest populations through fertility control, with products like Evolve rodent birth control enhancing pest management effectiveness [3] Company Overview - SenesTech is dedicated to creating healthier environments by managing animal pest populations humanely through fertility control [3] - The company's mission includes creating cleaner cities, more efficient businesses, and healthier communities with humane, effective, and sustainable products [3] Contact Information - For investor inquiries, Robert Blum from Lytham Partners can be contacted at 602-889-9700 [6] - Tom Chesterman, Chief Financial Officer of SenesTech, can be reached at 928-779-4143 for company-related inquiries [6]
SenesTech to Participate in the Lytham Partners 2025 Industrials & Basic Materials Investor Summit on April 1, 2025
Prnewswire· 2025-03-31 20:15
Core Insights - SenesTech, Inc. is participating in a webcast fireside chat at the Lytham Partners 2025 Industrials & Basic Materials Investor Summit on April 1, 2025 [1][2] - The company focuses on humane fertility control solutions for managing rodent populations, aiming to create healthier environments [3] Company Overview - SenesTech's products, such as Evolve rodent birth control, enhance pest management programs while reducing reliance on traditional poisons [3] - The company's mission includes creating cleaner cities, more efficient businesses, and healthier communities through humane and sustainable products [3] Event Details - The fireside chat is scheduled for 3:00 p.m. ET on April 1, 2025, and will be accessible via the conference home page [2] - A replay of the chat will be available through the same links, and one-on-one investor meetings can be arranged upon request [2]